Diffusion Pharmaceuticals Inc DFFN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:10 PM EDT
7.54quote price arrow down-0.39 (-4.92%)
Volume
223
Close
7.93quote price arrow up+0.30 (+3.93%)
Volume
9,635
52 week range
5.10 - 42.76
Loading...
  • Open7.63
  • Day High7.99
  • Day Low7.48
  • Prev Close7.63
  • 52 Week High42.76
  • 52 Week High Date06/30/21
  • 52 Week Low5.10
  • 52 Week Low Date04/28/22

Key Stats

  • Market Cap16.18M
  • Shares Out2.04M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change-48

KEY STATS

  • Open7.63
  • Day High7.99
  • Day Low7.48
  • Prev Close7.63
  • 52 Week High42.76
  • 52 Week High Date06/30/21
  • 52 Week Low5.10
  • 52 Week Low Date04/28/22
  • Market Cap16.18M
  • Shares Out2.04M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change-48

RATIOS/PROFITABILITY

  • EPS (TTM)-11.91
  • P/E (TTM)-0.67
  • Fwd P/E (NTM)-0.99
  • EBITDA (TTM)-15.839M
  • ROE (TTM)-56.91%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Diffusion Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development of therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed. The Company’s product candidate, Trans Sodium Crocetinate (TSC), is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The Company is focused on the development of TSC for the treatment of hypoxia and as a platform to enhance...
Address
300 EAST MAIN STREET, SUITE 201
Charlottesville, VA
22902
United States